530313 — Kimia Biosciences Share News
0.000.00%
- IN₹1.42bn
- IN₹1.76bn
- IN₹1.15bn
Brief: Kimia Biosciences Appoints Naveen Sharma As CFO
Brief: Kimia Biosciences Pradip Kumar Sharma Resigns as Chief Financial Officer
Brief: Kimia Biosciences Says Rakesh Chetani Resigns As CFO
Brief: Kimia Biosciences Gets Order Worth $200,000
Brief: Kimia Biosciences Says Filed Quality Product For API, Benfotiamine In European Union In Bulgaria
Brief: Kimia Biosciences Gets Confirmation For Active Substances Imported Into EU For Medical Products From India Govt
Brief: Kimia Biosciences Receives Written Confirmation For Active Substances Imported Into European Union
Brief: Kimia Biosciences Says Co Has Withdrawn Entire Contribution Of 51% From Magnizent Biochem LLP
Brief: Kimia Biosciences Appointed Rakesh Chetani As Chief Financial Officer
Brief: Kimia Biosciences Received Approval Of Advance Authorisation License Of Gliclazide BP An API
Brief: Kimia Biosciences Appoints Lakshay Prakash As CFO
Brief: Kimia Biosciences Re-Appoints Sameer Goel As MD
Brief: Kimia Biosciences CEO Suneel Kapur Resigns
Brief: Kimia Biosciences Names Suneel Kapur As CEO
Brief: Kimia Biosciences Gets Validated For Supply Of Pharmaceutical Raw Material, Bilastine To Bangladesh
Brief: Kimia Biosciences Says Sameer Goel Reappointed Chairman & MD
Brief: Kimia Biosciences Says Got India Drug Regulator Nod To Manufacture Bilastine
Brief: Kimia Biosciences Gets India Drug Regulator Nod To Manufacture Brivaracetam For Sale Or Distribution
Brief: Kimia Biosciences Gets Loan Licences To Manufacture Certain Drugs